Cover Story
June 2013

New Treatments Offer Hope for Advanced Prostate Cancer

New treatments for metastatic castration-resistant prostate cancer (CRPC) are gaining approval at a dizzying pace, and endocrinologists could play an important role in their use.

Read More

Features